...
首页> 外文期刊>Frontiers in Immunology >P2X7 Receptor Induces Tumor Necrosis Factor-α Converting Enzyme Activation and Release to Boost TNF-α Production
【24h】

P2X7 Receptor Induces Tumor Necrosis Factor-α Converting Enzyme Activation and Release to Boost TNF-α Production

机译:P2X7受体诱导肿瘤坏死因子-α转换酶的激活和释放,以促进TNF-α的产生。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Tumor necrosis factor (TNF)-α is a major pro-inflammatory cytokine produced in response to toll-like receptor stimulation. TNF-α release is controlled by the activity of TNF-α converting enzyme (TACE) that cut membrane-bound TNF-α to shed its ectodomain as a soluble cytokine. The purinergic receptor P2X ligand-gated ion channel 7 (P2X7) is activated in response to elevated concentrations of extracellular ATP and induces different pro-inflammatory pathways in macrophages to establish an inflammatory response. P2X7 receptor promotes the activation of the inflammasome and the release of interleukin-1β, the production of inflammatory lipids, and the generation of reactive oxygen species. In this study, we analyzed the mechanism of P2X7 receptor responsible of TNF-α release after priming macrophages with LPS doses ≤100?ng/ml. We found that P2X7 receptor increases the extracellular activity of TACE through the release of the mature form of TACE in exosomes. This effect was blocked using P2X7 receptor inhibitors or in macrophages obtained from P2X7 receptor-deficient mice. Elevation of intracellular Ca~(2+)and p38 mitogen-activated protein kinase after P2X7 receptor activation were involved in the release of TACE, which was able to process TNF-α on nearby expressing cells. Finally, we observed an increase of TNF-α in the peritoneal lavage of mice treated with LPS and ATP. In conclusion, P2X7 receptor induces the release of TACE in exosomes to the extracellular compartment that could amplify the pro-inflammatory signal associated to this receptor. These results are important for the development of therapeutics targeting P2X7 receptor.
机译:肿瘤坏死因子(TNF)-α是响应toll样受体刺激而产生的主要促炎细胞因子。 TNF-α的释放受TNF-α转换酶(TACE)的活性控制,该酶会切割与膜结合的TNF-α,使其胞外域作为可溶性细胞因子释放。嘌呤能受体P2X配体门控离子通道7(P2X7)响应高浓度的细胞外ATP而被激活,并在巨噬细胞中诱导不同的促炎途径,以建立炎症反应。 P2X7受体促进炎症小体的活化和白介素-1β的释放,炎性脂质的产生以及活性氧的产生。在这项研究中,我们分析了LPS剂量≤100?ng / ml引发巨噬细胞后P2X7受体负责TNF-α释放的机制。我们发现P2X7受体通过释放外泌体中成熟形式的TACE增加了TACE的细胞外活性。使用P2X7受体抑制剂或从P2X7受体缺陷型小鼠获得的巨噬细胞可阻断这种作用。 TACE的释放与P2X7受体激活后细胞内Ca〜(2+)和p38丝裂原活化蛋白激酶的升高有关,TACE的释放能够在附近表达的细胞上加工TNF-α。最后,我们观察到用LPS和ATP处理的小鼠腹腔灌洗液中TNF-α的增加。总之,P2X7受体诱导TACE在外泌体中释放到细胞外区室,这可能会放大与该受体相关的促炎信号。这些结果对于开发靶向P2X7受体的治疗剂是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号